Acanthocytosis and acute leukaemia.
McCarthy
D M
DM
Slater
N G
NG
Barrett
A J
AJ
D000050:Acanthocytes / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004913:Erythrocytes, Abnormal / Q000473:pathology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D003561:Cytarabine; D008130:Lomustine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003630:Daunorubicin